Connect Biopharma Holdings Limited
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CNTB and other ETFs, options, and stocks.About CNTB
Connect Biopharma Holdings Ltd. operates as clinical-stage biopharmaceutical company. It focuses on advancing rademikibart, an anti-interleukin-4-receptor alpha antibody, to transform acute and chronic care in asthma and chronic obstructive pulmonary disease.
CEOBarry D. Quart
CEOBarry D. Quart
Employees62
Employees62
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded2015
Founded2015
Employees62
Employees62
CNTB Key Statistics
Market cap139.76M
Market cap139.76M
Price-Earnings ratio-9.15
Price-Earnings ratio-9.15
Dividend yield—
Dividend yield—
Average volume108.55K
Average volume108.55K
High today$2.59
High today$2.59
Low today$2.47
Low today$2.47
Open price$2.55
Open price$2.55
Volume37.26K
Volume37.26K
52 Week high$3.28
52 Week high$3.28
52 Week low$0.51
52 Week low$0.51
Stock Snapshot
With a market cap of 139.76M, Connect Biopharma Holdings Limited(CNTB) trades at $2.50. The stock has a price-to-earnings ratio of -9.15.
During the trading session on 2026-03-05, Connect Biopharma Holdings Limited(CNTB) shares reached a daily high of $2.59 and a low of $2.47. At a current price of $2.50, the stock is +1.2% higher than the low and still -3.5% under the high.
Trading activity shows a volume of 37.26K, compared to an average daily volume of 108.55K.
The stock's 52-week range extends from a low of $0.51 to a high of $3.28.
The stock's 52-week range extends from a low of $0.51 to a high of $3.28.
People also own
Based on the portfolios of people who own CNTB. This list is generated using Robinhood data, and it’s not a recommendation.